Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.2B sold by 661 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Jason V Coloma CEOMAZEMaze Therapeutics, Inc.Planned sale$932K 34,501 shares at $27.02 15% of stakeTraded Oct 1 Filed Oct 2
-
Jennifer Tejada ChairPDPagerDuty, Inc.Planned sale$1.6M 107,000 shares at $15.11 6.4% of stakeTraded Sep 30 Filed Oct 2
-
Asif Ali CFOPTGXProtagonist Therapeutics, Inc.Planned sale$8.3M 58,629 shares at $141.78 50% of stakeTraded Sep 30 Filed Oct 2
-
Harold Bernstein President, R&D & CMOMAZEMaze Therapeutics, Inc.Planned sale$435K 16,141 shares at $26.93 100% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$10.3M 11,002 shares at $935.60 2.9% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$17.4M 18,998 shares at $914.67 4.8% of stakeTraded Oct 1 Filed Oct 2
-
Lee Shavel CEOVRSKVerisk Analytics, Inc.Planned sale$603K 3,535 shares at $170.70 3.5% of stakeTraded Oct 1 Filed Oct 2
-
Anita Gonzales VP and CAORVTYRevvity, Inc.Planned sale$13K 84 shares at $155.48 1.2% of stakeTraded Oct 1 Filed Oct 2
-
Matthew Siegel CFOOUTOUTFRONT Media Inc.Planned sale$696K 25,000 shares at $27.84 8.6% of stakeTraded Oct 1 Filed Oct 2
-
Vikas Bhalla President of EXLEXLSExlService Holdings, Inc.Planned sale$389K 11,000 shares at $35.38 9.1% of stakeTraded Oct 1 Filed Oct 2
-
James Edward Sklar EVP, Gen Counsel & SecretaryHGBLHeritage Global Inc.Planned sale$3,175 2,500 shares at $1.27 1% of stakeTraded Oct 1 Filed Oct 2
-
Ralph A LaRossa CEOPEGPublic Service Enterprise Group IncorporatedPlanned sale$141K 2,083 shares at $67.48 0.7% of stakeTraded Oct 1 Filed Oct 2
-
Terrance Lane Wilson SVP & General CounselWMBWilliams Companies, Inc. (The)Planned sale$136K 2,000 shares at $67.85 0.8% of stakeTraded Oct 1 Filed Oct 2
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$148K 3,190 shares at $46.42 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$207K 4,544 shares at $45.58 3% of stakeTraded Oct 1 Filed Oct 2
-
John T Hall CEOINTAIntapp, Inc.Planned sale$110K 3,000 shares at $36.70 0.1% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
David J. Bates COOXPOXPO, Inc.Planned sale$465K 2,615 shares at $177.93 4% of stakeTraded Oct 1 Filed Oct 2
-
Kyle Wismans CFOXPOXPO, Inc.Planned sale$132K 750 shares at $175.47 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Fang Jiang Chief People OfficerBABAAlibaba Group Holding LimitedSale$12M 885,272 shares at $13.55 16% of stakeTraded Sep 30 Filed Oct 2
-
Satish Dhanasekaran CEOKEYSKeysight Technologies Inc.Sale$1.1M 3,000 shares at $364.13 2.5% of stakeTraded Sep 30 Filed Oct 2
-
Nicholas Conrad Smith CFOANROAlto Neuroscience, Inc.Planned sale$3.6M 134,886 shares at $26.45 85% of stakeTraded Sep 29–30 Filed Oct 1
-
Chris Koopmans COOMRVLMarvell Technology, Inc.Planned sale$2.6M 10,000 shares at $262.05 4.6% of stakeTraded Oct 1 Filed Oct 1
-
Taylor Monnig COOCLSKCleanSpark, Inc.Planned sale$41K 3,335 shares at $12.33 1% of stakeTraded Oct 1 Filed Oct 1
-
Sanjit Biswas CEOIOTSamsara Inc.Planned sale$10M 263,900 shares at $38.03 23% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
John Bicket See RemarksIOTSamsara Inc.Planned sale$10M 263,900 shares at $38.03 21% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.65Traded Sep 29 Filed Oct 1
-
Rami Rahim EVP, Pres GM NetworkingHPEHewlett Packard Enterprise CompanyPlanned sale$2.1M 34,456 shares at $61.42 3.8% of stakeTraded Sep 29 Filed Oct 1
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApple Inc ComPlanned sale$806K 2,399 shares at $336.18 5.4% of stakeTraded Sep 29 Filed Oct 1
-
Steve Ladd Huffman CEORDDTReddit, Inc.Planned sale$2.5M 17,308 shares at $144.87 4.9% of stakeTraded Sep 29 Filed Oct 1
-
Alan B. Sandler Chief Development OfficerRVMDRevolution Medicines, Inc.Planned sale$1.3M 6,309 shares at $202.14 11% of stakeTraded Sep 29 Filed Oct 1
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$30.3M 48,667 shares at $623.03 13% of stakeTraded Sep 29–30 Filed Oct 1
-
Donna Roberts SVP, Chief HR OfficerCBRLCracker Barrel Old Country Store, Inc.Sale$182K 3,500 shares at $52.08 7.4% of stakeTraded Oct 1 Filed Oct 1
-
Jeffrey Bertolini COOCARLCarlsmed, Inc.Planned sale$3,400 243 shares at $13.99 1.1% of stakeTraded Sep 30 Filed Oct 1
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.7M 8,300 shares at $564.95 16% of stakeTraded Oct 1 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$1.1M 1,920 shares at $550.22 0.6% of stakeTraded Sep 30 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$3.9M 7,580 shares at $517.97 2.3% of stakeTraded Sep 30 Filed Oct 1
-
Nello Mainolfi CEOKYMRKymera Therapeutics, Inc.Planned sale$3.4M 30,000 shares at $113.80 4.3% of stakeTraded Oct 1 Filed Oct 1
-
Chi Fung Cheng Chief Technology OfficerCRDOCredo Technology Group Holding LtdPlanned sale$5.3M 27,500 shares at $193.93 0.5% of stakeTraded Sep 29 Filed Oct 1
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$90K 1,941 shares at $46.54 1.3% of stakeTraded Sep 30 Filed Oct 1
-
Ryan M. Daniels SVP, Wood ProductsRYNRayonier Inc.Planned sale$16K 887 shares at $18.56 1.6% of stakeTraded Sep 30 Filed Oct 1
-
George Kurian CEONTAPNetApp, Inc.Planned sale$10.5M 50,000 shares at $209.95 19% of stakeTraded Sep 29 Filed Oct 1
-
Haim Chera EVP - Head of RetailVNOVornado Realty TrustSale$3.1M 90,000 shares at $34.01 45% of stakeTraded Sep 29 Filed Oct 1
-
Cheryl Gault COORAPPRapport Therapeutics, Inc.Planned sale$332K 10,000 shares at $33.19 6.7% of stakeTraded Sep 30 Filed Oct 1
-
Tobin W Juvenal Chief Commercial OfficerCSTLCastle Biosciences, Inc.Planned sale$232K 6,577 shares at $35.29 11% of stakeTraded Sep 29–30 Filed Oct 1
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$355K 7,640 shares at $46.41 4.7% of stakeTraded Sep 29–30 Filed Oct 1
-
Matthew J Cox CEOMATXMatson, Inc.Planned sale$2.2M 10,000 shares at $222.33 4.4% of stakeTraded Sep 29 Filed Oct 1
-
Atul Dandekar CsboMAZEMaze Therapeutics, Inc.Planned sale$203K 7,500 shares at $27.06 19% of stakeTraded Sep 29 Filed Oct 1
-
Derek Gordon Schiller EVP, BusinessBATRKAtlanta Braves Holdings, Inc.Planned sale$9.3M 175,395 shares at $53.20 36% of stakeTraded Sep 30 Filed Oct 1
-
Gregory John Heller EVP, CLO & SecretaryBATRKAtlanta Braves Holdings, Inc.Planned sale$4.3M 80,263 shares at $53.89 78% of stakeTraded Sep 29 Filed Oct 1
-
Matthew M. Kim ComptrollerSOSouthern Company (The)Planned sale$8,273 100 shares at $82.73 2% of stakeTraded Oct 1 Filed Oct 1
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.